Kleespies Axel, Füessl Kathrin E, Seeliger Hendrik, Eichhorn Martin E, Müller Mario H, Rentsch Markus, Thasler Wolfgang E, Angele Martin K, Kreis Martin E, Jauch Karl-Walter
Department of Surgery, Klinikum Grosshadern, University of Munich (LMU), Marchioninistrasse 15, 81377 Munich, Germany.
Int J Colorectal Dis. 2009 Sep;24(9):1097-109. doi: 10.1007/s00384-009-0734-y. Epub 2009 Jun 3.
The benefit of elective primary tumor resection for non-curable stage IV colorectal cancer (CRC) remains largely undefined. We wanted to identify risk factors for postoperative complications and short survival.
Using a prospective database, we analyzed potential risk factors in 233 patients, who were electively operated for non-curable stage IV CRC between 1996 and 2002. Patients with recurrent tumors, resectable metastases, emergency operations, and non-resective surgery were excluded. Risk factors for increased postoperative morbidity and limited postoperative survival were identified by multivariate analyses.
Patients with colon cancer (CC = 156) and rectal cancer (RC = 77) were comparable with regard to age, sex, comorbidity, American Society of Anesthesiologists score, carcinoembryonic antigen levels, hepatic spread, tumor grade, resection margins, 30-day mortality (CC 5.1%, RC 3.9%) and postoperative chemotherapy. pT4 tumors, carcinomatosis, and non-anatomical resections were more common in colon cancer patients, whereas enterostomies (CC 1.3%, RC 67.5%, p < 0.0001), anastomotic leaks (CC 7.7%, RC 24.2%, p = 0.002), and total surgical complications (CC 19.9%, RC 40.3%, p = 0.001) were more frequent after rectal surgery. Independent determinants of an increased postoperative morbidity were primary rectal cancer, hepatic tumor load >50%, and comorbidity >1 organ. Prognostic factors for limited postoperative survival were hepatic tumor load >50%, pT4 tumors, lymphatic spread, R1-2 resection, and lack of chemotherapy.
Palliative resection is associated with a particularly unfavorable outcome in rectal cancer patients presenting with a locally advanced tumor (pT4, expected R2 resection) or an extensive comorbidity, and in all CRC patients who show a hepatic tumor load >50%. For such patients, surgery might be contraindicated unless the tumor is immediately life-threatening.
对于不可治愈的IV期结直肠癌(CRC)患者,择期行原发性肿瘤切除术的益处仍未明确。我们旨在确定术后并发症及短期生存的危险因素。
利用前瞻性数据库,我们分析了1996年至2002年间因不可治愈的IV期CRC而接受择期手术的233例患者的潜在危险因素。排除复发性肿瘤、可切除转移灶、急诊手术及非切除性手术患者。通过多因素分析确定术后发病率增加及术后生存受限的危险因素。
结肠癌(CC = 156)和直肠癌(RC = 77)患者在年龄、性别、合并症、美国麻醉医师协会评分、癌胚抗原水平、肝转移、肿瘤分级、切缘、30天死亡率(CC 5.1%,RC 3.9%)及术后化疗方面具有可比性。pT4肿瘤、癌性腹膜炎及非解剖性切除在结肠癌患者中更常见,而直肠手术后肠造口术(CC 1.3%,RC 67.5%,p < 0.0001)、吻合口漏(CC 7.7%,RC 24.2%,p = 0.002)及总手术并发症(CC 19.9%,RC 40.3%,p = 0.001)更为频繁。术后发病率增加的独立决定因素为原发性直肠癌、肝肿瘤负荷>50%及合并症累及>1个器官。术后生存受限的预后因素为肝肿瘤负荷>50%、pT4肿瘤、淋巴转移、R1 - 2切除及未行化疗。
对于局部进展期肿瘤(pT4,预期R2切除)或合并症广泛的直肠癌患者,以及所有肝肿瘤负荷>50%的CRC患者,姑息性切除与特别不利的结局相关。对于此类患者,除非肿瘤立即危及生命,否则手术可能为禁忌。